Talk:Valdecoxib
This is the talk page for discussing improvements to the Valdecoxib article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Valdecoxib.
|
I, Hitesh Chavda, P.G.student from India want to know the standard curve of valecoxib. Can you give few information about this curve.
- Please ask the reference desk. JFW | T@lk 13:18, 5 Apr 2005 (UTC)
nomenclature[edit]
Folkes, If I am not mistaken the heterocyclic moiety of Bextra should be an "Isoxazol". Can somebody rectify this? Thanks —Preceding unsigned comment added by Chzapf (talk • contribs)
- Corrected. Thank you for noticing. Fvasconcellos 15:21, 8 October 2006 (UTC)
availability[edit]
The infobox says it's withdrawn in the US, EU, Canada and parts of Asia - is there anywhere it is still available? Are there any chances of it being reintroduced in the markets it's been withdrawn from?
2009 settlement[edit]
Currently the article goes into quite a bit of detail about the legal issues related to off-label promotion. This content is not really about valdecoxib - there were several drugs involved, not just valdecoxib. This section is much more relevant to the pharmaceutical companies involved/ I feel that it could be mentioned here, but not in such detail that it dominates the article text as it does now. It should be trimmed considerably. -- Ed (Edgar181) 14:34, 20 December 2012 (UTC)
I came to this page from a google search precisely because I was interested in reading about the legal issues and the large fine... You can add links in a 'see also' section to the other drugs involved but I think that if you put this information on the main page of the pharma company it will be harder to find, read and reference. This is a very short article and keeping this info here doesn't harm it in any way - in fact it makes it more useful for a general audience. 124.177.161.93 (talk) 04:23, 15 February 2013 (UTC)